0IGA.L

Emergent BioSolutions Inc. [0IGA.L] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

0IGA.L Stock Summary

Top 10 Correlated ETFs

0IGA.L


Top 10 Correlated Stocks

0IGA.L


In the News

0IGA.L Financial details

Company Rating
Neutral
Market Cap
127.38M
Income
-757.2M
Revenue
1.05B
Book val./share
12.51
Cash/share
2.15
Dividend
-
Dividend %
-
Employees
1.6K
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
-0.14
Forward P/E
0.7
PEG
-0.01
P/S
0.1
P/B
0.12
P/C
1.19
P/FCF
-0.43
Quick Ratio
-
Current Ratio
-
Debt / Equity
1.33
LT Debt / Equity
0.69
-
-
EPS (TTM)
-14.83
EPS next Y
3.67
EPS next Q
-0.83
EPS this Y
251.9%
EPS next Y
-124.77%
EPS next 5Y
-93.19%
EPS last 5Y
NAN%
Revenue last 5Y
-1.05%
Revenue Q/Q
2.26%
EPS Q/Q
-81.3%
-
-
-
-
SMA20
-
SMA50
50%
SMA100
50%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-71%
ROC
-
Gross Margin
22%
Oper. Margin
-18%
Profit Margin
-72%
Payout
-
Shs Outstand
52.2M
Shs Float
50.07M
-
-
-
-
Target Price
-
52W Range
1.48-13.4182
52W High
-80.29%
52W Low
+156.2%
RSI
52
Rel Volume
0.37
Avg Volume
19.43K
Volume
7.13K
Perf Week
2.48%
Perf Month
50.71%
Perf Quarter
-10.11%
Perf Half Y
-19.94%
-
-
-
-
Beta
1.216
-
-
Volatility
0.05%, 0.49%
Prev Close
-1.08%
Price
2.562
Change
0.87%

0IGA.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
21.4829.5133.1522.3120.49
Net income per share
1.065.794.1-4.22-14.85
Operating cash flow per share
3.6510.175.99-0.68-4.03
Free cash flow per share
1.967.51.8-7.86-5.04
Cash per share
3.2611.7910.77132.18
Book value per share
21.1427.4630.1227.712.68
Tangible book value per share
1.559.8114.628.812.68
Share holders equity per share
21.1427.4630.1227.712.68
Interest debt per share
16.5817.2216.3628.9218.76
Market cap
2.76B5.3B2.41B578.66M121.86M
Enterprise value
3.43B5.59B2.71B1.36B887.66M
P/E ratio
50.6117.3711-2.73-0.16
Price to sales ratio
2.493.411.360.520.12
POCF ratio
14.679.897.54-16.97-0.59
PFCF ratio
27.2813.4225.13-1.47-0.47
P/B Ratio
2.533.661.50.420.19
PTB ratio
2.533.661.50.420.19
EV to sales
3.13.591.531.220.85
Enterprise value over EBITDA
13.729.175.29-136.25-20.69
EV to operating cash flow
18.2310.428.46-39.95-4.3
EV to free cash flow
33.914.1428.2-3.46-3.44
Earnings yield
0.020.060.09-0.37-6.24
Free cash flow yield
0.040.070.04-0.68-2.12
Debt to equity
0.750.610.531.021.33
Debt to assets
0.350.310.290.450.47
Net debt to EBITDA
2.680.470.58-78.38-17.85
Current ratio
3.173.113.40.981.04
Interest coverage
3.5618.0513.45-4.27-1.78
Income quality
3.451.761.460.160.27
Dividend Yield
00000
Payout ratio
0.140.05000
Sales general and administrative to revenue
00000
Research and developement to revenue
0.20.130.130.170.1
Intangibles to total assets
0.430.320.280.30
Capex to operating cash flow
-0.46-0.26-0.710.540.25
Capex to revenue
-0.08-0.09-0.13-0.32-0.05
Capex to depreciation
-0.78-1.23-1.77-2.41-0.4
Stock based compensation to revenue
0.020.030.020.04-0.26
Graham number
22.4359.852.7351.365.1
ROIC
0.050.160.11-0.05-0.12
Return on tangible assets
0.040.160.1-0.1-0.41
Graham Net
-14.62-9.26-7.26-16.62-14.96
Working capital
469.9M811.4M895.9M-18.5M28.2M
Tangible asset value
80M517.2M782M440.7M649.3M
Net current asset value
-552.6M-240.3M-76.3M-568.2M-506.1M
Invested capital
0.750.610.531.021.33
Average receivables
268.9M253.1M254.9M219.05M175.1M
Average payables
87.75M115.45M132.5M116.2M107.85M
Average inventory
214.15M264.75M325.75M347.6M339.8M
Days sales outstanding
90.8554.1857.45266.44
Days payables outstanding
74.0389.9858.5450.3454.11
Days of inventory on hand
173.75202.96156.45170.58158.63
Receivables turnover
4.026.746.367.025.49
Payables turnover
4.934.066.247.256.75
Inventory turnover
2.11.82.332.142.3
ROE
0.050.210.14-0.15-1.17
Capex per share
-1.69-2.68-4.19-7.18-1.01

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
6.633.296.665.225.33
Net income per share
-1.76-3.65-5.15-5.08-0.95
Operating cash flow per share
1.86-3.67-2.261.160.62
Free cash flow per share
1.39-3.97-2.50.920.4
Cash per share
13.058.691.755.122.15
Book value per share
27.8123.9618.8613.4612.51
Tangible book value per share
8.837.482.8713.4612.51
Share holders equity per share
27.8123.9618.8613.4612.51
Interest debt per share
28.5828.3318.5117.1417.07
Market cap
576.35M521.83M374.67M173.01M123.52M
Enterprise value
1.36B1.51B1.21B965.11M889.32M
P/E ratio
-1.64-0.71-0.36-0.16-0.62
Price to sales ratio
1.743.161.110.640.45
POCF ratio
6.21-2.84-3.282.883.85
PFCF ratio
8.33-2.62-2.953.655.97
P/B Ratio
0.420.430.390.250.19
PTB ratio
0.420.430.390.250.19
EV to sales
4.119.123.573.573.22
Enterprise value over EBITDA
-83.44-13.4525.639.55-78.01
EV to operating cash flow
14.66-8.19-10.5416.0927.7
EV to free cash flow
19.66-7.57-9.520.3642.96
Earnings yield
-0.15-0.35-0.7-1.52-0.4
Free cash flow yield
0.12-0.38-0.340.270.17
Debt to equity
1.021.170.951.241.33
Debt to assets
0.450.480.420.460.47
Net debt to EBITDA
-48.09-8.7917.6532.46-67.18
Current ratio
0.980.981.081.071.04
Interest coverage
-3.94-7.220.45-0.21-1.89
Income quality
-1.051.010.44-0.23-0.65
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
0.170.240.080.050.11
Intangibles to total assets
0.30.280.3700
Capex to operating cash flow
-0.250.080.11-0.21-0.36
Capex to revenue
-0.07-0.09-0.04-0.05-0.04
Capex to depreciation
-0.57-0.44-0.38-0.43-0.37
Stock based compensation to revenue
0.040.040.020.07-0.02
Graham number
33.2244.3346.7739.2416.39
ROIC
-0.03-0.060.010-0.02
Return on tangible assets
-0.04-0.09-0.19-0.14-0.03
Graham Net
-16.69-20.12-14.58-11.42-14.76
Working capital
-18.5M-21.5M54.2M47.4M28.2M
Tangible asset value
440.7M375.5M145.3M697.2M649.3M
Net current asset value
-568.2M-553M-475.1M-484.5M-506.1M
Invested capital
1.021.170.951.241.33
Average receivables
175.25M157.55M223M253.3M203.75M
Average payables
103.65M113.85M116.25M110.5M112.45M
Average inventory
448.5M359.3M361.1M354.2M341.5M
Days sales outstanding
43.3384.9877.2772.0362.15
Days payables outstanding
39.2964.9547.1656.0150.04
Days of inventory on hand
133.12192.39154.27175.97146.68
Receivables turnover
2.081.061.161.251.45
Payables turnover
2.291.391.911.611.8
Inventory turnover
0.680.470.580.510.61
ROE
-0.06-0.15-0.27-0.38-0.08
Capex per share
-0.47-0.3-0.25-0.24-0.22

0IGA.L Frequently Asked Questions

What is Emergent BioSolutions Inc. stock symbol ?

Emergent BioSolutions Inc. is a US stock , located in Gaithersburg of Md and trading under the symbol 0IGA.L

What is Emergent BioSolutions Inc. stock quote today ?

Emergent BioSolutions Inc. stock price is $2.562 today.

Is Emergent BioSolutions Inc. stock public?

Yes, Emergent BioSolutions Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap